| Literature DB >> 33869987 |
Delaney Clayton1, Michael B Chavez1, Michelle H Tan1, Tamara N Kolli1, Priscila A Giovani1,2, Kimberly J Hammersmith3,4, Sasigarn A Bowden5,6, Brian L Foster1.
Abstract
Entities:
Keywords: CEMENTUM; DENTIN; HYPOPHOSPHATEMIA; MINERALIZED TISSUE/DEVELOPMENT; PERIODONTAL TISSUES/PERIODONTIUM; RICKETS
Year: 2021 PMID: 33869987 PMCID: PMC8046057 DOI: 10.1002/jbm4.10463
Source DB: PubMed Journal: JBMR Plus ISSN: 2473-4039
Demographic, Genetic, and Biochemical Results, Treatment Regimens Including Surgical Intervention to Correct Leg Deformity, Treatment Complication (Nephrocalcinosis), and Teeth Analyzed for Enrolled Individuals
| Parameter | Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 |
|---|---|---|---|---|---|---|
| Sex, M/F | F | M | F | F | M | F |
| Age at time of data collection, y | 10 | 5 | 9 | 12 | 6 | 12 |
| Age at diagnosis, y | 5 | 0.9 | 3.3 | 0.9 | 1.3 | 2.8 |
| Height Z‐score | −1.6 | −1.8 | −1.2 | −3.4 | −2.5 | −1.9 |
| Genetic mutation(s) in | N/A |
C.850–2 A > G IVS7‐2 A > G |
c.1544A > C p.Q515P |
IVS2‐ c.187 + 1delG | Sibling of patient 4 (presumed same mutation) | c.1368G > A p.W456X |
| Serum calcium (normal 8–10.5 mg/dL) | 10.1 | 9.6 | 9.6 | 10.2 | 9.6 | 9.0 |
| Serum phosphorus (age‐dependent reference range; mg/dL) |
At diagnosis:
Age 9 y |
Age 3 y
|
At diagnosis:
Age 8 y
|
At diagnosis:
Age 11 y |
At diagnosis:
Age 5y 9 mo
|
At diagnosis:
Age 11 y
|
| Serum alkaline phosphatase (age‐ and sex‐ dependent reference range; U/L) |
At diagnosis: Age 9 y (151–342) |
Age 3 y
(100–320) |
At diagnosis:
Age 8 y
|
At diagnosis:
Age 11 y 345 (137–424) |
At diagnosis: 356 (85–360) Age 5y 5 mo 295 (151–342) |
At diagnosis:
Age 11 y |
| Serum 25‐hydroxy vitamin D at diagnosis (normal 20–40 ng/mL) | 44 | N/A | 27 | 55 | 37 | 55 |
| Serum 1,25 dihydroxy vitamin D at diagnosis (normal 15–90 pg/mL) | 34 | N/A | 51 | 58 | 38 | 68 |
| PTH (normal 10–65 pg/L) |
At diagnosis: 54 Age 9 y: 51 |
Age 3 y (18–80) |
At diagnosis: 51 Age 8 y |
At diagnosis: 56 Age 11 y |
At diagnosis: Age 5 y 5 mo |
At diagnosis: Age 11 y |
| Serum FGF23 (normal ≤230 RU/mL) | 169 | N/A | 158 | N/A | 167 |
|
| Treatments with age at the start of treatment |
5 y: Calcitriol and phosphate 9 y 5 mo: Burosumab |
0.9 y: Calcitriol and phosphate 4 y: Burosumab |
3 y: Calcitriol and phosphate 8 y: Burosumab |
0.9 y: Calcitriol and phosphate 11 y 2 mo: Burosumab |
1.3 y: Calcitriol and phosphate 5 y 9 mo: Burosumab |
2 y 8 mo: Calcitriol and phosphate 11 y: Burosumab |
| Guided growth surgery of legs | Yes | No | No | No | No | No |
| Nephrocalcinosis | No | Yes | No | No | No | Yes |
| Teeth analyzed, No. | 1 | 3 | 3 | 1 | 6 | 1 |
| Teeth types, A‐T | D | O, P, Q | F, N, O | P | C, D, F, G, N, P | C |
Note: The ages in years denote the time point of the majority of lab testing performed for respective patients. Bold font indicates values outside of the normal range.
Abbreviations: FGF23, fibroblast growth factor 23; PHEX, phosphate‐regulating endopeptidase homolog, X‐linked.
Indicates laboratory results obtained while patients were on calcitriol and phosphate treatment.
Fig 1Clinical and radiographic effects of X‐linked hypophosphatemia rickets (XLH) on the dentition. (A) Dental panoramic, periapical, and bitewing radiographs from a representative healthy control individual at ages of 7 years 11 months, eight years five months, and 11 years 8 months. (B) Bitewing radiographs from XLH patient 1 aged 8 years 4 months showing normal enamel, dentin, and pulp chamber appearance. (C) Bitewing radiographs from patient 3 at 9 years of age showing normal enamel, dentin, and pulp chamber appearance. (D) Panoramic and bitewing radiographs from patient 6 aged 11 years 6 months shows relatively normal pulp chambers and canals in the adult dentition. (E) Periapical and bitewing radiographs from patient 2 aged 3 years indicate thin enamel, thin dentin, and enlarged pulp chambers in anterior teeth. (F) Oral photographs from patient 5 aged 3 years 6 months show the presence of fistulas (yellow arrows) near maxillary incisors. Periapical and bitewing radiographs show thin enamel, thin dentin, and enlarged pulp chambers.
Fig 2Primary teeth from patients with X‐linked hypophosphatemia rickets (XLH). Representative (A) three‐dimensional and (B) two‐dimensional (2D) renderings from μCT scans showing representative primary teeth from a healthy control individual and patients 1–6. Enamel (EN) is shown in white and dentin (DE) is shown in gray. Yellow dotted boxes in panel (B) indicate areas shown at higher magnification in (C) illustrating mild and severe levels of hypomineralized interglobular dentin (radiolucent regions). (D) Transverse 2D images of representative teeth showing hypomineralized interglobular dentin (<450 mg/cm3) where DE is shown in white to visualize interglobular dentin in green. Mildly affected patients with XLH exhibited little to no obvious interglobular dentin. Severely affected individuals had substantial accumulation of interglobular dentin.
Fig 3Mineralization defects associated with X‐linked hypophosphatemia rickets (XLH) in primary teeth. (A‐I) Individual values, means, and SDs from μCT analyses of dental tissues of patients with XLH versus control individuals. Control 95% CIs are shaded in gray. Patients 1–6 are color coded to recognize patterns in data across measurements. Mt.D = Mantle dentin (outermost); Cp.D = circumpulpal dentin (middle); Pp.D = proximal pulpal dentin (inner and last formed). (J) Measured volumes of interglobular dentin. Values for mildly affected patients with XLH fall within the 95% CI, and values for severely affected patients are substantially elevated above the 95% CI.
Fig 4Histological features of dentin and cementum in primary teeth associated with X‐linked hypophosphatemia rickets (XLH). (A) Toluidine blue staining revealed interglobular dentin defects (white spaces, indicated by red stars) in all teeth from all patients with XLH with varying severity. (B) Predentin in XLH‐affected teeth is wide with an erratic border compared with controls (red stars). (C) Acellular cementum (AC; white arrowhead in control section) was observed on the root surfaces of all XLH‐affected teeth, though thinner for patients 2 and 5. (D) Picrosirius red staining observed under polarized light microcopy showed organized Sharpey's fibers within the cementum layer. Teeth from patients 2 and 5 exhibited reduced signal and organization. (E) Quantitative analysis confirmed in XLH‐affected teeth 45‐fold increased interglobular dentin and eightfold increased predentin thickness based on toluidine blue staining patterns, whereas mean cementum thickness was decreased 50% in XLH teeth, and individual measurements fell below the 95% CI established by healthy controls.